Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.1
40.23%
60%
—
120.28%
80%
—
5 Years
Score6.1
Net Growth40.23%
Net Trend60%
Net Income Consistency—
Rev Growth120.28%
Rev Trend80%
Revenue Consistency—
Neuropace Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 45M to $ 99M and net income went from -$ 36M to -$ 21M. Revenue increased in 80% of the years measured; net income in 60%.
Neuropace Inc currently holds a 5-year HDB Score of 6.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 14.56 | — |
1 Year2025-08-12 | $ 9.13 | 59.47% |
5 Years2021-08-12 | $ 21.66 | -32.78% |
All Time2021-04-22 | $ 24.96 | -41.67% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-04-22 |
|---|---|---|---|---|
| Price | $ 14.56 | $ 9.13 | $ 21.66 | $ 24.96 |
| Return | — | 59.47% | -32.78% | -41.67% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 99M | -$ 21M | $ 53M |
| 2025 | $ 99M | -$ 21M | $ 61M |
| 2024 | $ 79M | -$ 27M | $ 52M |
| 2023 | $ 65M | -$ 32M | $ 66M |
| 2022 | $ 45M | -$ 47M | $ 77M |
| IPO2021 | $ 45M | -$ 36M | $ 115M |
Explore beyond NPCE
You're looking at Neuropace Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
